MichaelJClare-SalzlerMD

PubMed

• 7 citations
  The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.
  Kimberly J. Newsom, Yuan Zhang, Srikar Chamala, Katherine A. Martinez, Michael J. Clare-Salzler, Petr Starostik> ;Journal of Clinical Laboratory Analysis. 2021 Jul 2
• 12 citations
  The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)
  Teresa Buckner, Lauren A. Vanderlinden, Brian C. DeFelice, Patrick M. Carry, Katerina Kechris, Fran Dong, Oliver Fiehn, Brigitte I. Frohnert, Michael Clare-Salzler, Ma...> ;Diabetologia. 2021 Apr 24
• 5 citations
  Collection and Storage of Human Plasma for Measurement of Oxylipins.
  Kristen J. Polinski, Michael Armstrong, Jonathan Manke, Jennifer Seifert, Tessa L. Crume, Fan Yang, Michael J. Clare-Salzler, V. Michael Holers, Nichole Reisdorph, Jil...> ;Metabolites. 2021 Feb 26
• 1 citations
  Optimizing COVID-19 testing capabilities and clinical management using pathology informatics
  Srikar Chamala, Sherri Flax, Petr Starostik, Kartikeya Cherabuddi, Nicole M. Iovine, Siddardha Majety, Kimberly J. Newsom, Mary Reeves, Michael J Joshi-Guske, Maggie M...> ;JAMIA Open. 2021 Feb 15
• 5 citations
  Pathology Informatics and Robotics Strategies for Improving Efficiency of COVID-19 Pooled Testing
  Balaji Balasubramani, Kimberly J. Newsom, Katherine A. Martinez, Petr Starostik, Michael J. Clare-Salzler, Srikar Chamala> ;Academic Pathology. 2021 Jan 1
• 10 citations
  Association of lipid mediators and development of future incident inflammatory arthritis in an anti‐citrullinated protein antibody positive population
  Kristen J. Polinski, Elizabeth A. Bemis, Fan Yang, Tessa L. Crume, M. Kristen Demoruelle, Marie L. Feser, Jennifer Seifert, James R. O'Dell, Ted R. Mikuls, Michael H. ...> ;Arthritis & Rheumatology. 2021 Apr 23
• 9 citations
  Predictors of oxylipins in a healthy pediatric population.
  Teresa Buckner, Lauren A. Vanderlinden, Randi K. Johnson, Brian C. DeFelice, Patrick M. Carry, Jennifer Seifert, Kathleen Waugh, Fran Dong, Oliver Fiehn, Michael Clare...> ;Pediatric Research. 2021 May 1
• 7 citations
  Informatics Training for Pathology Practice and Research in the Digital Era
  Heather T. D. Maness, Linda S. Behar-Horenstein, Michael J. Clare-Salzler, Srikar Chamala> ;Academic Pathology. 2020 Mar 30
• 92 citations
  Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes
  Marco Infante, Camillo Ricordi, Janine Sanchez, Michael J. Clare-Salzler, Nathalia Padilla, Virginia Fuenmayor, Carmen Chavez, Ana Alvarez, David A. Baidal, Rodolfo Al...> ;Nutrients. 2019 Sep 11
• 50 citations
  Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model
  Jamal S. Lewis, Joshua M. Stewart, Gregory P Marshall, Matthew R. Carstens, Ying Zhang, Natalia V. Dolgova, Chang-Qing Xia, Todd M. Brusko, Clive Wasserfall, Michael J...> ;ACS Biomaterials Science & Engineering. 2019 Mar 26
• 91 citations
  CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
  D. Max Smith, Kristin Weitzel, Amanda R. Elsey, Taimour Y. Langaee, Yan Gong, Dyson T. Wake, Benjamin Q. Duong, Melanie G. Hagen, Christopher A. Harle, Elvira Mercado,...> ;Genetics in Medicine. 2019 Jan 23
• 8 citations
  Vitamin D and Omega 3 Field Study on Progression of Type 1 Diabetes.
  Camillo Ricordi, Michael J. Clare-Salzler, Marco Infante, C Baggerly, J Aliano, S McDonnell, S Chritton> ;Cellr4-- Repair, Replacement, Regeneration, & Reprogramming. 2019 Jan 1
• 48 citations
  Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hypergl...
  Ronghua Hu, Chang-Qing Xia, Edward J. Butfiloski, Michael J. Clare-Salzler> ;Clinical Immunology. 2018 Oct 1
• 177 citations
  Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes
  Federica Vecchio, Nicola Lo Buono, Angela Stabilini, Laura Nigi, Matthew J. Dufort, Susan Geyer, Paola M.V. Rancoita, Federica Cugnata, Alessandra Mandelli, Andrea Val...> ;JCI Insight. 2018 Sep 20
• 14 citations
  Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trial.
  Scott A. Mosley, J. Kevin Hicks, Diane Portman, Kristine A. Donovan, Priya K. Gopalan, Jessica M. Schmit, Jason S. Starr, Natalie L. Silver, Yan Gong, Taimour Y. Langa...> ;Contemporary Clinical Trials. 2018 Mar 10
• 23 citations
  Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned
  Kristin Weitzel, D. Max Smith, Amanda R. Elsey, Benjamin Q. Duong, Benjamin Burkley, Michael J. Clare-Salzler, Yan Gong, Tara A. Higgins, Benjamin Kong, Taimour Y. Lan...> ;Clinical and Translational Science. 2018 Mar 1
• 13 citations
  Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
  Jeannette Lo, Chang-Qing Xia, Ruihua Peng, Michael J. Clare-Salzler> ;Journal of Immunology Research. 2018 Feb 14
• 188 citations
  Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
  Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees, Rhonda M. Cooper-DeHoff, Julio D. Duarte, Deepak Voora, Stephen E. Kimmel, Caitrin W. McDonough, Yan Gong, Chi...> ;JACC. Cardiovascular Interventions. 2018 Jan 22
• 35 citations
  The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population.
  Ryan W. Gan, Elizabeth A. Bemis, M. Kristen Demoruelle, Christopher C. Striebich, Stacey Brake, Marie L. Feser, LauraKay Moss, Michael J. Clare-Salzler, V. Michael Hol...> ;Rheumatology. 2017 Dec 1
• 28 citations
  Enrichment of IL-17A + IFN-γ + and IL-22 + IFN-γ + T cell subsets is associated with reduction of NKp44 + ILC3s in the terminal ileum of Crohn's disease patients
  Jian Li, Andria L. Doty, Ying Tang, Dalton Berrie, Atif Iqbal, Sanda A. Tan, Michael J. Clare-Salzler, Shannon M. Wallet, Sarah C. Glover> ;Clinical and Experimental Immunology. 2017 Jul 7
• 39 citations
  Type 1 Interferons Potentiate Human CD8+ T Cell Cytotoxicity Through a STAT4 and Granzyme B Dependent Pathway
  Brittney N. Newby, Todd M. Brusko, Baiming Zou, Mark A. Atkinson, Michael J. Clare-Salzler, Clayton E. Mathews> ;Diabetes. 2017 Sep 4
• 26 citations
  Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas.
  Virginie S. E. Jean-Baptiste, Chang-Qing Xia, Michael J. Clare-Salzler, Marc S. Horwitz> ;Ebiomedicine. 2017 Aug 1
• 55 citations
  Institutional profile: University of Florida Health Personalized Medicine Program.
  Larisa H. Cavallari, Kristin Weitzel, Amanda R. Elsey, Xinyue Liu, Scott A. Mosley, Donald M. Smith, Benjamin Staley, Almut G. Winterstein, Carol A. Mathews, Francesco...> ;Pharmacogenomics. 2017 Mar 27
• 60 citations
  Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis
  Ryan W. Gan, M. Kristen Demoruelle, Kevin D. Deane, Michael H. Weisman, Jane H. Buckner, Peter K. Gregersen, Ted R. Mikuls, James R. O'Dell, Richard M. Keating, Tasha ...> ;Annals of the Rheumatic Diseases. 2017 Jan 1
• 44 citations
  Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis.
  Toral Zaveri, Natalia V. Dolgova, Jamal S. Lewis, Kiri Hamaker, Michael J. Clare-Salzler, Benjamin G. Keselowsky> ;Biomaterials. 2017 Jan 1
• Join now to see all

Journal Articles

• A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history  
  Sosenko JM, Skyler JS, DiMeglio LA, Beam CA, Krischer JP, Greenbaum CJ, Boulware D, Rafkin LE, Matheson D, Herold KC, Mahon J, Palmer JP; Type Diabetes TrialNet Study ..., Diabetes Care, 1/1/2015
• Racial-ethnic disparities in management and outcomes among children with type 1 diabetes  
  Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, Nadeau KJ, Kittelsrud JM, Huckfeldt P, Beck RW, Lipman TH; T1D Exchange Clinic Network, Pediatrics, 1/1/2015
• The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months  
  Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Pre..., Diabetes Care, 1/1/2015
• Autologous Umbilical Cord Blood Infusion Followed by Oral Docosahexaenoic Acid and Vitamin D Supplementation for C-Peptide Preservation in Children with Type 1 Diabetes  
  Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Wingard JR, Theriaque DW, Shuster JJ, Ferguson RJ, Kozuch M, Clare-Salzler M, Atkinson MA, Schatz DA, Biol Blood Marrow Transplant, 1/1/2013
• The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation  
  Shuldiner AR, Relling MV, Peterson JF, Hicks JK, Freimuth RR, Sadee W, Pereira NL, Roden DM, Johnson JA, Klein TE; Pharmacogenomics Research Network Translational Phar..., Clin Pharmacol Ther, 1/1/2013
• Anti-lymphocyte antibody-based immunotherapy in type 1 diabetes  
  Xia CQ, Liu YT, Guan QB, Clare-Salzler M, Chin Med J (Engl), 1/1/2013
• Institutional Profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics  
  Johnson JA, Elsey AR, Clare-Salzler MJ, Nessl D, Conlon M, Nelson DR, Pharmacogenomics, 1/1/2013
• Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials  
  Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC, Marks JB, Raskin P, Sanda S, Schatz D, Wherrett DK, Wilson DM, Krischer JP, S..., Lancet, 1/1/2013
• The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis  
  Diabetes Research in Children Network (DirecNet) Study Group; Type 1 Diabetes TrialNet Study Group, Buckingham BA, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA,..., Diabetes Technol Ther, 1/1/2013
• Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry  
  Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, Bergenstal RM, Harris B, Dubose SN, Miller KM, Beck RW; T1D Exchange Clinic Network, J Clin Endocrinol Metab, 1/1/2013
• The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients  
  Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Pr..., Diabetes Care, 1/1/2013
• Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants  
  Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP Type 1 Diabetes TrialNet and Diabetes Prevention Trial–..., Diabetes, 1/1/2013
•  
  Buckingham B, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA, DiMeglio LA, Bremer AA, Slover R, Tamborlane WV; Diabetes Research in Children Network (DirecNet) St..., Diabetes Care, 1/1/2013
• Rapamycin/IL-2 Combination Therapy in Patients with Type 1 Diabetes Augments Tregs yet Transiently Impairs beta-Cell Function  
  Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, Ahmann A, Rabinovitch A, Aggarwal S, Phippard D, Turka LA, Ehlers MR, Bianchine PJ, Boyle KD, Adah SA, Blu..., Diabetes, 1/20/2012
• Total synthesis of grassystatin A, a probe for cathepsin E function  
  Yang S, Zhang W, Ding N, Lo J, Liu Y, Clare-Salzler MJ, Luesch H, Li Y, Bioorg Med Chem, 1/1/2012
• Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice  
  Xia CQ, Chernatynskaya AV, Wasserfall CH, Wan S, Looney BM, Eisenbeis S, Williams J, Clare-Salzler MJ, Atkinson MA, BMC Immunol, 1/1/2012
• Pre-transplant myeloid dendritic cell deficiency associated with cytomegalovirus infection and death after kidney transplantation  
  Sun Q, Hall EC, Huang Y, Chen P, Dibadj K, Murawski M, Shraybman R, Van Kirk K, Tang V, Peng R, Patton PR, Clare-Salzler MJ, Kaplan B, Segev DL, Womer KL, Transpl Infect Dis, 1/1/2012
• Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array  
  Johnson JA, Burkley BM, Langaee TY, Clare-Salzler MJ, Klein TE, Altman RB, Clin Pharmacol Ther, 1/1/2012
• Antibacterial effects of zinc oxide nanorod surfaces  
  Jansson T, Clare-Salzler MJ, Zaveri TD, Mehta S, Dolgova NV, Chu BH, Ren F, Keselowsky BG, J Nanosci Nanotechnol, 1/1/2012
• Fall in C-peptide Over First Two Years from Diagnosis: Evidence of At Least Two Distinct Phases from Composite TrialNet Data  
  Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM, Type 1 ..., Diabetes, 1/1/2012
• Performance of Glycated Hemoglobin (HbA1c) as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth  
  Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers M, Schatz DA, Krischer JP, and the TEDDY, TRIGR, Diabetes Prevention Trial-Typ..., Diabetes Care, 1/1/2012
• Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice  
  Davoodi-Semiromi A, Wasserfall CH, Xia CQ, Cooper-Dehoff RM, Wabitsch M, Clare-Salzler M, Atkinson M, PLoS One, 1/1/2012
• Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies  
  Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL; Type 1 Diabetes TrialNet Stud..., Diabetes Care, 1/1/2012
• The T1D Exchange clinic registry  
  Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network, J Clin Endocrinol Metab, 1/1/2012
• Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity:...  
  Miller MR, Yin X, Seifert J, Clare-Salzler M, Eisenbarth GS, Rewers M. Norris JM, Pediatric Diabetes, 1/24/2011
• Join now to see all

Books/Book Chapters

• Diabetes 1991: Proceedings of the 14th International Diabetes Federation Congress 
  Chapter: GAD autoimmunity in IDDM. 
  Kaufman, D.L. +. Erlander, M.D., Clare-Salzler, M., Atkinson, M., Maclaren, N.K., and Tobin A.J.Editors: H. Rifkin, J.A., Colwell, S.I. Taylor.Elsevier Science Publishers, Amsterdam1991

Abstracts/Posters

• STAT5 Dysfunction,GM-CSF Hyper-Responsiveness, & Aberrant Monocyte/Macrophage Prostaglanding Synthase 2 Expression in Type 1 Diabetes
  Litherland S.A., Peng R.H., Li, Y., Clare-Salzler, M.J, Keystone Symposium, 1/1/2002
• Defective Maturation of Myeloid Dendritic Cells (DC) in NOD Mice is controlled by IDD.
  Bahjat K, Li Y., Peng R.H., Clare-Salzler M.J., American Diabetes Association Meeting, Copper Mountain, CO, 1/1/2002
• Abnormalities in Peripheral Blood Dendritic Cell Populations in Type 1 Diabetes.
  Peng R.H., Li Y., Brezner K., Clare-Salzler M.J., American Diabetes Association Meeting, Copper Mountain, CO, 1/1/2002
• Type 1 Diabetic Monocyte Prostaglandin Synthase 2 Activity Impairs T Cell Activation Induced Cell Death by Suppressing IL2 Signaling
  Xie T.X., Litherland, S.A., Whittaker D.S., Bahjat K, Grebe, K.M., Selvaraj, L., Wasserfall, C., Peck, A.B., Moldawer, L.L., Clare-Salzler, M.J., FASEB/Experimental Biology/AAI Annual Meeting, 1/1/2001
• Defective of Myeloid Dendritic Cells (DC) in NOD Mice is controlled in Part by Genes within the Idd10 Susceptibility Loci.
  Bahjat, K., Whittaker, D., Clare-Salzler, M.J., Keystone Symposium, 1/1/2001
• Aberrant Monocyte Prostaglandin Synthase 2 Activity in type 1 Diabetes Impairs T Cell IL2 Signaling and Activation Induced Cell Death.
  Litherland ,S.A., Whittaker, D., Bahjat, K.S., Peck, A.B., Clare-Salzer, M.J., Moldawer, L.L., Keystone Symposium, 1/1/2001
• Dysfunctional GM-CSF-Mediated Transcriptional Regulation in Type 1 Diabetes & Pre-diabetic Human Monocytes & Nonobese Diabetic (MOD) Mouse Macrophages
  Litherland, S.A., Davoodi-Semironi A., Li. Y., Clare-Salzler, M.J., Keystone Symposium: Regulation of Immunity and Autoimmunity, 1/1/2001
• Increased Survival By Local Expression of Human Interleukin-10 In the Lymphnode in Murine Polymicrobial Sepsis.
  Oberholzer,O.A., LaFace, Clare-Salzler,M.J., Surgical Infection Society, 1/1/2001
• High-dose Indomethacin Does Not Cause Intestinal Damage in Infant Rats: What is the Mechanism?
  Manish, R., Patel, B.S., Clare-Salzler, M.J., 1/1/2001
• Malleability of autoimmune disease phenotypes.
  Mizutani A., Behney K.M., Litherland S.A., Clare-Salzler M., Richards H.B., Reeves W.H., American College of Rheumatology (ACR) 64th Annual Scientific meeting, Philadelphia, PA, 1/29/2000
• Genetic Determination of TNF Mediated Liver apoptosis.
  Bahjat, F.R., Clare-Salzler, M.J., Moldawer, L.L., 5th World Congress on Trauma, Shock, Inflammation and Sepsis, 1/1/2000
• Prolonged GM-CSF activation of STAT5 in type 1 diabetes: Possible mechanism for aberrant prostaglandin synthase 2 (PGS2) expressions by autoimmune monocytes and macrop...
  Litherland S.A., Xie T., Davoodi-Semironi R., Schatz D., Clare-Salzler M.J., FASEB Summer Research Conference, 1/1/2000
• Genetic polymorphism in the response to lipopolysaccharide and D-galactosamine in the mouse.
  Bahjat F.R., Clare-Salzler, M.J., Moldawer L.L., Surgical Infection Society, 1/1/2000
• Immunology of Diabetes Society Conference, Prostaglandin Synthase 2 Expression as a Risk Assessment Tool for IDDM. A New Avenue for Prevention & Intervention?
  Clare-Salzler, M, Immunology of Diabetes Society Proceedings, 1/1/1999
• Defect in AICD in the NOD mouse.
  Bahjat K.S., Bahjat F.R., Whitaker D.S., Xie T., Wakeland E., Auffenberg T., L. L., Moldawer, Clare-Salzler, M.J., Keystone Meeting, Autoimmunity and Tolerance, 1/1/1999
• Autoimmunity & Tolerance. Dysregulation of Prostaglandin Synthase 2 (PGS2) in Autoimmunity: IL10 Resistance & STAT5 Regulation.
  Litherland, S.A., Whittaker, D.S., Grebe, K.M., Clare-Salzler, M.J., Keystone Meeting, Autoimmunity and Tolerance, 1/1/1999
• Divergent regulation of IL-12 by PGE2 in monocyte derived dendritic cells.
  Whittaker, D.S., Clare-Salzler M. J., Keystone Meeting, Autoimmunity and Tolerance, 1/1/1999
• Prostaglandin Synthase 2 expression as a risk assessment tolol fo IDDM: A new avenue for prevention and intervention?
  Litherland, S.A., Xie T., Muir A., Schatz D., She J-X., Atkinson M., Clare-Salzler M.J., Immunology of Diabetes Meeting Proceedings, 1/1/1999
• Regions of NOD mouse chromosome 17 and chromosome 1 control AICD in the NOD Mouse.
  Bahjat, K.S., Whittaker, D.S., Moldawer, L.L., Clare-Salzler, M.J., etc, Immunology of Diabetes Society Meeting Proceedings, 1/1/1999
• Prostaglandin Synthase 2 Expression as a Risk Assessment Tool for IDDM. A New Avenue for Prevention & Intervention?
  Litherland, S.A., Xie,T., Muir, A., Clare-Salzler, M.J., Immunology of Diabetes Society Proceedings, 1/1/1999
• CPP32 Dysregulation in NOD mice.
  Bahjat, K., Clare-Salzler M.J., Immunology of Diabetes Society Proceedings, Chicago, IL, 1/1/1998
• Monocyte Prostaglandin synthase 2 (PGS2) produced prostaglandin E2 (PGE2) inhibits activated T cell IL2 and Il2 receptor alpha (CD25) expression: A mechanism for the l...
  Litherland, S.A., Xie, T.X., Whittaker, D.S., Moldawer L.L., Clare-Salzler M.J., Immunology of Diabetes Society Proceedings, Chicago, IL, 1/1/1998
• Aberrant Monocyte Prostaglandin Synthase-2 (PGS-2) expression: A novel cellular marker for IDDM risk.
  Litherland, S.A., Xie, T.X., Whittaker, D.S., Schatz D., Moldawer L.L., Clare-Salzler M.J., Immunology of Diabetes Society Proceedings, Chicago, IL, 1/1/1998
• Human monocyte derived dendritic cells (DC) express prostaglandin synthase-2 Impact on DC function.
  Whittaker D.S., Clare-Salzler M.J., Cellular and Molecular Biology of Dendrite Cells. Keystone Symposia on Dendritic Cell Biology, Santa Fe, NM, 1/1/1998
• Characterization of monocyte derived dendritic cells (DC) from pre-IDD subjects: Effects of endogenous prostanoids on IL-12 production.
  Whittaker, D.S., Clare-Salzler M.J., Immunology of Diabetes Society Meeting Proceedings, 1/1/1998
• Join now to see all

Lectures

• Interferon biology in Type 1 Diabetes 
  Chania, Crete - 1/1/2015
• Type 1 Diabetes Immunogenetic-Environmental Interactions on the Pathway to Disease 
  1/1/2014
• Nutritional Intervention to Prevent Autoimmune Type 1 Diabetes 
  1/1/2014
• Omega-3 fatty acids; Mechanisms of Action and Effects on Inflammatory Disease 
  1/1/2010
• The Role of Type 1 Interferons in Type 1 Diabetes Pathogenesis 
  1/1/2009
• Nutritional Intervention to Prevent Type 1 Diabetes: Progress Report 
  1/1/2008
• Eicosanoid Metabolism in Macrophages; Regulation of Pro-Inflammatory and Resolving Lipid Molecules 
  1/1/2007
• Nutrition, Inflammation, and Type 1 Diabetes 
  University of Florida, College of Medicine - 1/1/2006
• Type 1 IFN in Type 1 Diabetes Pathogenesis; Relationship to Organ Specificity and Disease Acceleration 
  1/1/2005
• Abnormal Eicosanoid Metabolism in Type 1 Diabetes: Can we make a Foe an Ally? 
  Baltimore, MD - 1/1/2004
• Dexamethasone Induces Development of IL-10 Producing Dendritic Cells Derived from Human Monocytes: Implications for Application of These Dendritic Cells for Prevention... 
  Cambridge, England - 1/1/2004
• Resolvin Metabolism and the Pathogenesis of Type 1 Diabetes in the NOD Mouse 
  Cambridge, England - 1/1/2004
• Unique Signature of Stat5B in Regulatory CD4+25+ T Cell 
  Cambridge, England - 1/1/2004
• Eicosanoid and Omega-3 Fatty Acid Mediated Resolution of Inflammation 
  1/1/2003
• Dendritic Cell Biology and the NOD Mouse 
  1/1/2001
• Cox-2 in the Immunopathogenesis of Type-1 Diabetes in Mice and Humans 
  Gainesville, FL - 1/1/1999
• Immunophenotypes/Genotypes Contributing to the Autoimmune Response of NOD Mice 
  1/1/1999
• The Role of PGS2 in Type 1 Diabetes 
  Gainesville, FL - 1/1/1998
• Immunology of Diabetes Society Meeting, "Aberrant monocyte prostaglandin synthase-2 expression inhibits IL2 and IL2 receptor (CD25) expression in IDD T cells 
  Oak Brook, IL - 1/1/1998
• Tumor Necrosis Factor binding protein (TNF-bp) deuces neutropenia and loss of FAS positive peripheral blood leukocytes in septic baboons 
  Munich, Germany - 1/1/1997
• The Neuroendocrine-Immune System 
  1/1/1997
• Cellular Immune Markers and Modeling Risk for Immune Mediated Diabetes 
  1/1/1997
• Regulation of prostaglandin synthase (PGS-2) expression in NOD macrophage. 
  Canberra, Australia - 1/1/1996
• Compartmentalization of Tolerance in the Pancreatic Lymph Nodes (PLN) of NOD mice 
  Chantilly, France - 1/1/1995
• The Role of Prostaglandin Synthase-2 in the Immunopathogenesis of Diabetes in NOD Mice and Pre-Diabetic Humans 
  Gainesville, FL - 1/1/1995
• Join now to see all